Individuals living with HIV are at increased risk of vaccine-preventable diseases due to their compromised immune systems. The impact of these diseases on this population is multifaceted, affecting not only their health outcomes but also their quality of life and overall healthcare burden. This review explores the implications of vaccine-preventable diseases in people with HIV, examining how their immunocompromised status makes them more susceptible to infections that vaccines typically prevent. The review also addresses the effectiveness of vaccines in this group, the challenges in vaccination practices, and the strategies for improving vaccine uptake and efficacy among HIV-positive individuals. By synthesizing current research and guidelines, this paper aims to highlight the critical need for tailored vaccination strategies and enhanced healthcare measures to mitigate the risk of vaccine-preventable diseases in this vulnerable population.
HTML PDFShare this article
Journal of AIDS & Clinical Research received 5264 citations as per Google Scholar report
